The positive vehicle result in the US data set is highly irregular and looks, on the face of it, to be an error. This would have been obvious to those conducting the trial and would/should have been double and triple checked. A report from them on why/if we should have confidence in the anomolous result would be useful.
- Forums
- ASX - By Stock
- BOT
- Ann: BTX 1503 Acne Phase 2 Study Results Presentation
Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-85
-
-
- There are more pages in this discussion • 566 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
|
|||||
Last
38.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $687.8M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1500 | 38.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.0¢ | 12568 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1500 | 0.385 |
5 | 21250 | 0.380 |
1 | 40 | 0.375 |
2 | 16983 | 0.370 |
4 | 466054 | 0.365 |
Price($) | Vol. | No. |
---|---|---|
0.370 | 444 | 1 |
0.375 | 27500 | 2 |
0.380 | 290841 | 15 |
0.385 | 220411 | 9 |
0.390 | 815895 | 13 |
Last trade - 09.42am 16/07/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online